274 results on '"J, Langhorst"'
Search Results
2. Distinct Alterations in Central Pain Processing of Visceral and Somatic Pain in Quiescent Ulcerative Colitis Compared to Irritable Bowel Syndrome and Health
- Author
-
H Öhlmann, L R Lanters, N Theysohn, J Langhorst, H Engler, A Icenhour, and S Elsenbruch
- Subjects
Gastroenterology ,Medizin ,General Medicine - Abstract
Background and Aims Despite relevance to pain chronicity, disease burden, and treatment, mechanisms of pain perception for different types of acute pain remain incompletely understood in patients with inflammatory bowel disease (IBD). Building on experimental research across pain modalities, we herein addressed behavioral and neural correlates of visceral versus somatic pain processing in women with quiescent ulcerative colitis (UC) compared to irritable bowel syndrome (IBS) as a patient control group, and healthy women (HC). Methods Thresholds for visceral and somatic pain were assessed with rectal distensions and cutaneous thermal pain, respectively. Using functional magnetic resonance imaging, neural and behavioral responses to individually calibrated and intensity-matched painful stimuli from both modalities were compared. Results Pain thresholds were comparable across groups, but visceral thresholds correlated with gastrointestinal symptom severity and chronic stress burden exclusively within UC. Upon experience of visceral and somatic pain, both control groups demonstrated enhanced visceral pain-induced neural activation and greater perceived pain intensity, whereas UC patients failed to differentiate between pain modalities at both behavioral and neural levels. Conclusions When confronted with acute pain from multiple bodily sites, UC patients’ responses are distinctly altered. Their failure to prioritize pain arising from the viscera may reflect a lack of adaptive behavioral flexibility possibly resulting from long-lasting central effects of repeated intestinal inflammatory insults persisting during remission. The role of psychological factors, particularly chronic stress, in visceral sensitivity and disease-specific alterations in the response to acute pain call for dedicated mechanistic research as a basis for tailoring interventions for intestinal and extraintestinal pain symptoms in IBD. more...
- Published
- 2023
Catalog
3. Ingwer in der Phytotherapie: Fokus Onkologie
- Author
-
Tanja Neufeld, Katrin Pfuhlmann, J. Langhorst, and Petra Klose
- Subjects
Pharmacology ,03 medical and health sciences ,Cancer Research ,0302 clinical medicine ,Complementary and alternative medicine ,030220 oncology & carcinogenesis ,030221 ophthalmology & optometry ,Medizin - Abstract
ZUSAMMENFASSUNGIngwer ist eine tropische Pflanze, welche im Wurzelstock 1,5–3% ätherisches Öl enthält. Ingwer fördert die Magenentleerung und den Magen-Darm-Transit und kann einen kurzfristigen Effekt bei der Behandlung und Prävention von Übelkeit und Erbrechen hervorrufen. Als in Pulverform anerkannte Arznei findet sie auch in der Onkologie Verwendung. Es konnte gezeigt werden, dass Ingwer bei Chemotherapie-induzierter Übelkeit/Erbrechen (CINV) behilflich sein könnte. Es gibt Hinweise, dass höhere Ingwerdosen weniger wirksam sind oder vorhandene Symptome verstärken können. Es liegen erste Ergebnisse vor, dass die Tagesdosis von 1 g nicht überschritten werden sollte. Weiterhin zeigte sich in einer Studie mit fraglicher Qualität, dass mit Ingwer behandelte Ovarialkarzinompatientinnen weniger Metastasen im Vergleich zur Kontrollgruppe aufwiesen. Studien, welche den Einfluss von Ingwer auf die Lebensqualität untersuchten, zeigen keine einheitlichen Ergebnisse. Weitere qualitative hochwertige Studien sind nötig, um die medizinische Wirksamkeit des Ingwers im onkologischen Kontext bestätigen und in der Praxis etablieren zu können. more...
- Published
- 2021
- Full Text
- View/download PDF
4. Wind Affected Maneuverability of Tugboat-Controlled Ships
- Author
-
M. Höffmann, A. Berger, J. Langhorst, O. Struß, T. Schnauder, W. Bergmann, Christof Büskens, K. Chan, S. Roy, and Mahmood Shubbak
- Subjects
Bad weather ,System of differential equations ,Wind force ,Control and Systems Engineering ,Computer science ,Traffic volume ,Container (abstract data type) ,Admissible set ,Set (psychology) ,Optimal control ,Marine engineering - Abstract
The development of maritime transportation, in terms of the size and traffic volume of container ships, is increasingly posing technical challenges especially in crowded harbors and narrow canals. To ensure safe and efficient operation, tugboats are used for assisting large ships in such critical areas under the supervision of the responsible pilots. However, the mis-assessment of risk, especially under bad weather conditions, can lead to accidents, economic losses, and even casualties. Accordingly, the need for automated assistant systems is strong. In this paper, we investigate the maneuverability of tugboat-controlled ships under the influence of wind. We provide a characterization of the admissible set of safe wind situations for the execution of a given maneuver in terms of a constrained system of differential equations. Under some restrictions over the type of maneuvers, we prove the star-convexity of the admissible set. For this purpose, the dynamical model of the ship motion is derived, which takes tugboat and wind forces into account. The star-convexity of the sought-after set and the ship model allow for an efficient approximation of this set by optimal control methods. As an application, we propose a visual aid that allows the tugboat pilots to clearly distinguish between safe and hazardous wind situations during maneuver planning. more...
- Published
- 2021
- Full Text
- View/download PDF
5. Addendum zu den S3-Leitlinien Morbus Crohn und Colitis ulcerosa: Betreuung von Patienten mit chronisch entzündlichen Darmerkrankungen in der COVID-19-Pandemie – offene Fragen und Antworten
- Author
-
C. Veltkamp, J. Zemke, L. Kanbach, J. H. Niess, J. Büning, L. Leifeld, Petra Lynen, K. Herrlinger, B. Kaltz, E. Schnoy, N. Teich, J. Preiβ, T. Andus, F. Hartmann, W. Häuser, P. Hartmann, J. Stein, Ch Maaser, P. Kienle, J. Langhorst, A. Thomann, J. Walldorf, E. F. Stange, St Fichtner-Feigl, Ulf Helwig, Carsten Schmidt, H. Matthes, Irina Blumenstein, M. Kreis, A. Schreyer, J. Klaus, S. In der Smitten, J. Ockenga, F. Autschbach, Axel Dignaβ, K. Kannengieβer, W. Kruis, S. Zeiβig, A. Lügering, D. Bettenworth, Ch Treese, M. Reinshagen, R. Atreya, J. Däbritz, E. Rijcken, O. Bachmann, Ph Esters, B. Bokemeyer, A. Pace, Sibylle Koletzko, T. Brechmann, Britta Siegmund, K. Aden, P. Bufler, Andreas Sturm, Torsten Kucharzik, C. Ott, K. M. Keller, G. Moog, C. Gross, M. Götz, A. J. Kroesen, R. Ehehalt, J de Laffolie, T. Kühbacher, J. C. Hoffmann, U. Böcker, Andreas Stallmach, and K. Fellermann more...
- Subjects
Questions and answers ,medicine.medical_specialty ,Coronavirus disease 2019 (COVID-19) ,Pneumonia, Viral ,Disease ,Inflammatory bowel disease ,Betacoronavirus ,Crohn Disease ,Germany ,Pandemic ,medicine ,Humans ,Infection control ,Intensive care medicine ,Pandemics ,Leitlinie ,Crohn's disease ,SARS-CoV-2 ,business.industry ,Risk of infection ,Gastroenterology ,COVID-19 ,Outbreak ,Inflammatory Bowel Diseases ,medicine.disease ,Dermatology ,Ulcerative colitis ,Practice Guidelines as Topic ,Colitis, Ulcerative ,Erratum ,Coronavirus Infections ,business - Abstract
ZusammenfassungDie COVID-19-Pandemie ist ein weltweiter Ausbruch von neu aufgetretenen Infektionen mit dem SARS-CoV-2-Virus, von denen weltweit derzeit mehr als 10.670.000 Menschen erkrankt sind bzw. waren. In Deutschland leiden ca. 450.000 Patienten an einer chronisch entzündlichen Darmerkrankung; diese Patienten benötigen in der Regel eine kontinuierliche und kompetente Betreuung. Vor dem Hintergrund eines rasch zunehmenden Wissenszuwachses haben 68 Experten, die die derzeit gültigen Leitlinien der DGVS zum Morbus Crohn und zur Colitis ulcerosa erstellt haben, im Rahmen einer virtuellen Konferenz aktuelle und praxisnahe Empfehlungen formuliert, um die Versorgung von CED-Patienten zu verbessern. Diese adressieren das Infektionsrisiko einschließlich des Risikos für besondere Gruppen, den möglichen Verlauf der Erkrankung und die Konsequenzen für die medikamentöse und die operative Therapie der Grunderkrankung sowie allgemeine Maßnahmen zur Infektionsprävention und adjuvante Präventions- und Therapiemöglichkeiten. more...
- Published
- 2020
6. Management der frühen rheumatoiden Arthritis
- Author
-
S Heberger, Uta Kiltz, Matthias Schneider, C. Weseloh, Ch. Specker, Philipp Sewerin, O Funken, J Langhorst, S. Seitz, R Tholen, G Baseler, P Klose, B Richter, R. Oltman, Wilfried Mau, Klaus Krüger, and Michael Witthöft more...
- Subjects
medicine.medical_specialty ,Rheumatology ,business.industry ,medicine ,MEDLINE ,Arthritis ,Guideline ,Early rheumatoid arthritis ,medicine.disease ,Intensive care medicine ,business - Published
- 2020
- Full Text
- View/download PDF
7. Integrative Gastroenterologie in klinischer Versorgung und Forschung
- Author
-
J Langhorst
- Published
- 2021
- Full Text
- View/download PDF
8. [Management of early rheumatoid arthritis : Interdisciplinary guideline]
- Author
-
M, Schneider, G, Baseler, O, Funken, S, Heberger, U, Kiltz, P, Klose, K, Krüger, J, Langhorst, W, Mau, R, Oltman, B, Richter, S, Seitz, P, Sewerin, R, Tholen, C, Weseloh, M, Witthöft, and C, Specker
- Subjects
Arthritis, Rheumatoid ,Practice Guidelines as Topic ,Humans - Published
- 2020
9. Nutzung von Cannabis bei chronisch entzündlichen Darmerkrankungen in Deutschland
- Author
-
R Lauche, W Häuser, D Schröder, L Kairey, and J Langhorst
- Published
- 2019
- Full Text
- View/download PDF
10. Strukturierte Lebensstilmodifikation bei Patienten mit Colitis ulcerosa – Eine randomisierte kontrollierte Studie
- Author
-
Gustav Dobos, Mohamed Ahmed, Dirk Haller, Margarita Schöls, Holger Cramer, Sigrid Elsenbruch, J Langhorst, Zehra Cinar, R Lauche, Anna K. Koch, Ronja Eilert, and Kerstin Kofink
- Published
- 2019
- Full Text
- View/download PDF
11. LB01 SIX WEEKS OF SOFOSBUVIR/LEDIPASVIR TREATMENT OF ACUTE HEPATITIS C VIRUS GENOTYPE 1 MONOINFECTION: FINAL RESULTS OF THE THE GERMAN HEPNET ACUTE HCV IV STUDY
- Author
-
K. Deterding, C.D. Spinner, E. Schott, T.M. Welzel, G. Gerken, H. Klinker, U. Spengler, J. Wiegand, J. Schulze zur Wiesch, A. Pathil, M. Cornberg, A. Umgelter, C. Zöllner, S. Zeuzem, A. Papkalla, K. Weber, S. Hardtke, H. Leyen, A. Koch, D. Witzendorff, M. Manns, H. Wedemeyer, C.M. Preda, C.P. Popescu, C. Baicus, M. Manuc, R. Voiosu, E. Ceausu, L. Fulger, A. Nisanian, C.S. Pop, A. Oproiu, A. Arezzo, R. Passera, A. Bullano, Y. Mintz, A. KEDAR, L. Boni, E. Cassinotti, R. Rosati, U. Fumagalli, M. Sorrentino, M. Brizzolari, N. Di Lorenzo, A.L. Gaspari, D. Andreone, E. De Stefani, G. Navarra, S. Lazzara, M. Degiuli, K. Shishin, I. Khatkov, I. Kazakov, R. Schrittwieser, T. Carus, A. Corradi, G. Sitzman, A. Lacy, S. Uranues, A. Szold, M.A. Bonino, M. Morino, J. Strömberg, G. Sandblom, R. Coelen, M. Gaspersz, T. Labeur, J. Vugt, S. Dieren, F. Willemssen, C.Y. Nio, J. IJzermans, H.‐J. Klümpen, B. Groot Koerkamp, T. Gulik, R. Sturgess, D. Palmer, J. Trojan, A. Hoffmeister, B. Neu, S. Kasper, A. Dechêne, C. Jürgensen, J. Schirra, R. Jakobs, A. Høgset, L. Finnesand, A.E. Abd Elrazek, S. Saab, T. Salem, M. Abdel‐Aty, B. Hawary, A. Ismail, M. Zayied, M. Alboraie, R. Orenstein, E. Dubberke, C.H. Lee, S. Khanna, G. Hecht, S. Wong, T. Kwong, X. Wang, R.S.Y. Tang, S.C. Ng, J.J.Y. Sung, J. Yu, S. Ott, G.H. Waetzig, A. Rehmann, J. Moltzau‐Anderson, R. Bharti, J.A. Grasis, L. Cassidy, A. Tholey, H. Fickenscher, D. Seegert, P. Rosenstiel, S. Schreiber, T. Mazzawi, G.A. Lied, M. El‐Salhy, O.H. Gilja, J.G. Hatlebakk, T. Hausken, S.T. Witt, O. Bednarska, A. Icenhour, S. Elsenbruch, M. Ström, J.D. Söderholm, M. Engström, E.A. Mayer, Å. Keita, S. Walter, P.K. Kump, P. Wurm, H.P. Gröchenig, H.H. Wenzl, W. Petritsch, B. Halwachs, M. Wagner, V. Stadlbauer‐Köllner, A.J. Eherer, K.M. Hoffmann, A. Deutschmann, G. Reicht, L. Reiter, P. Slawitsch, G. Gorkiewicz, C. Hoegenauer, Y. Zhou, R. Kakuturu, D. Jung, K.K. Jørgensen, I.C. Olsen, G.L. Goll, M. Lorentzen, N. Bolstad, E.A. Haavardsholm, K.E. Lundin, C. Mørk, J. Jahnsen, T.K. Kvien, B.G. Feagan, B.E. Sands, G. Rossiter, X. Li, K. Usiskin, X. Zhan, J.‐F. Colombel, W.J. Sandborn, J. Panés, M. Ferrante, E. Louis, G. D'Haens, D. Franchimont, A. Kaser, O. Dewit, U. Seidler, K.‐J. Kim, M.F. Neurath, P. Scholl, S. Visvanathan, S.J. Padula, I. Herichova, N. Sha, D. Hall, W.O. Böcher, F. Bloemendaal, A. Levin, M. Wildenberg, P. Koelink, S. Verbeek, J. Claassens, B. Mcrae, G. Vidarsson, G.R. Brink, M. Badke, S. Rose‐John, M.E. Spehlmann, L. Peyrin‐Biroulet, J. Gatlin, M. Soloman, D. Unett, H. Al‐Shamma, D. Behan, J. Langhorst, J. Boone, A. Rueffer, G. Dobos, K. Beiderwellen, T. Lauenstein, W.S. Ngu, R. Bevan, Z.P. Tsiamoulos, P. Bassett, Z. Hoare, M. Rutter, N. Totton, T.J. Lee, A.V. Ramadas, J. Silcock, J. Painter, L.J. Neilson, B.P. Saunders, C.J. Rees, A. Schmidt, S. Goelder, H. Messmann, M. Goetz, T. Kratt, A. Meining, M. Birk, J. Delius, M. Albert, J.Y.W. Escher, A. Lau, R. Hoffman, K. Wiest, null Caca, A. Siddiqui, D. Wilson, M. Cangelosi, R. Rameshshanker, P. Wall, K. Cocks, T. Doulton, A. Yusuf, C. Hancock, R. Valori, A. Aravani, J. Rashbass, S. Vernon, E.J.A. Morris, J.H. ‐Choi, D.‐W. Seo, T.J. Song, D.H. Park, S.S. Lee, S.K. Lee, ‐H. Kim, P. Somani, and M. Sharma more...
- Subjects
0301 basic medicine ,Ledipasvir ,Sofosbuvir ,business.industry ,Gastroenterology ,Virology ,Virus ,03 medical and health sciences ,chemistry.chemical_compound ,030104 developmental biology ,0302 clinical medicine ,Oncology ,chemistry ,Genotype ,Medicine ,030211 gastroenterology & hepatology ,Acute hepatitis C ,business ,medicine.drug - Published
- 2016
- Full Text
- View/download PDF
12. Aktuelles zur Phytotherapie in den Leitlinien
- Author
-
J Langhorst
- Published
- 2017
- Full Text
- View/download PDF
13. Phytotherapie – Innovation in der Klinik
- Author
-
J Langhorst
- Published
- 2017
- Full Text
- View/download PDF
14. [Complementary and alternative procedures for fibromyalgia syndrome : Updated guidelines 2017 and overview of systematic review articles]
- Author
-
J, Langhorst, P, Heldmann, P, Henningsen, K, Kopke, L, Krumbein, H, Lucius, A, Winkelmann, B, Wolf, and W, Häuser
- Subjects
Complementary Therapies ,Evidence-Based Medicine ,Fibromyalgia ,Consensus Development Conferences as Topic ,Germany ,Practice Guidelines as Topic ,Humans ,Societies, Medical ,Randomized Controlled Trials as Topic - Abstract
The regular update of the guidelines on fibromyalgia syndrome, AWMF number 145/004, was scheduled for April 2017.The guidelines were developed by 13 scientific societies and 2 patient self-help organizations coordinated by the German Pain Society. Working groups (n =8) with a total of 42 members were formed balanced with respect to gender, medical expertise, position in the medical or scientific hierarchy and potential conflicts of interest. A search of the literature for systematic reviews of randomized controlled trials of complementary and alternative therapies from December 2010 to May 2016 was performed in the Cochrane library, MEDLINE, PsycINFO and Scopus databases. Levels of evidence were assigned according to the classification system of the Oxford Centre for Evidence-Based Medicine version 2009. The strength of recommendations was formed by multiple step formalized procedures to reach a consensus. Efficacy, risks, patient preferences and applicability of available therapies were weighed up against each other. The guidelines were reviewed and approved by the board of directors of the societies engaged in the development of the guidelines.Meditative movement therapies (e.g. qi gong, tai chi and yoga) are strongly recommended. Acupuncture and weight reduction in cases of obesity can be considered. more...
- Published
- 2017
15. Wirksamkeit und Sicherheit von magensaftresistentem Phosphatidylcholin-Granulat (LT-02) in der Remissionsinduktion bei Colitis ulcerosa Patienten mit ungenügendem Ansprechen auf Mesalazin: eine randomisierte, doppelblinde, Plazebo-kontrollierte Studie
- Author
-
A Dignaß, W Reinisch, M Horyński, O Poyda, P Armerding, J Langhorst, K Fellermann, T Kühbacher, G Novacek, P Hasselblatt, J Stein, P Übel, H Heinemann, R Müller, R Greinwald, and W Stremmel
- Subjects
Gastroenterology - Published
- 2018
- Full Text
- View/download PDF
16. Urtikaria
- Author
-
J. Langhorst, Bettina Wedi, D. Wieczorek, and Alexander Kapp
- Subjects
Gynecology ,medicine.medical_specialty ,business.industry ,medicine ,Dermatology ,business - Abstract
Bei der chronischen spontanen Urtikaria, den physikalischen Urtikariaformen und den Urtikariasonderformen ist ein gezieltes diagnostisches Vorgehen empfehlenswert. Dabei liegt der Schwerpunkt auf subklinischen bakteriellen und viralen Foci. Hierbei wird besonders haufig eine Infektion mit Helicobacter pylori nachgewiesen. Nicht selten kann eine Autoimmunurtikaria mittels autologem Serumtest diagnostiziert werden. Als unspezifische Werte sind bei der akuten Urtikaria die Zahl der Leukozyten im Blutbild und C-reaktives Protein manchmal hilfreich (hinweisend auf subklinische Infekte). In der Regel ist keine weitere Diagnostik indiziert. Besonders bei langjahrigen Verlaufen, ohne dass ein Triggerfaktor identifiziert werden kann, sowie bei entsprechenden anamnestischen Hinweisen bei intermittierend auftretenden Urtikariaschuben kann eine erweiterte Diagnostik mit Berucksichtigung von moglichen IgE-vermittelten Reaktionen (α-Gal und ω-5-Gliadin) wegweisend sein. Das seit einigen Jahren in unserer Sprechstunde an einer Universitats-Hautklinik erfolgreich eingesetzte Vorgehen kann aktuell individuell durch rezent identifizierte Einzelallergene bzw. Allergenkomponenten komplettiert werden. Der vorliegende Beitrag soll unser Vorgehen exemplarisch darstellen. more...
- Published
- 2013
- Full Text
- View/download PDF
17. Naturheilkunde und Komplementärmedizin in medizinischen Leitlinien
- Author
-
J. Langhorst
- Published
- 2016
- Full Text
- View/download PDF
18. Aktuelles zu Phytopharmaka in den Leitlinien – eine Standortbestimmung
- Author
-
J Langhorst
- Subjects
Pharmacology ,Complementary and alternative medicine - Published
- 2016
- Full Text
- View/download PDF
19. Anaphylaxie und Insektengiftallergie
- Author
-
Franziska Ruëff, R. Szczepanski, Alexander Kapp, U. Gieler, M. Schmies, Martine Grosber, Katja Nemat, M. Nassiri, A. Köhli, A. Helbling, Bettina Wedi, L. Klimek, Knut Brockow, E. Rietschel, D. Wieczorek, M. Wenzel, F. Balck, Werner Aberer, M. Babina, S. Krengel, Oliver Hausmann, R. Treudler, Claudia Kugler, D. Koschel, J. Fischer, T. Hawranek, C. Pföhler, K. Zimmer, J. Ring, P. Spornraft-Ragaller, U. Müller, S. Hompes, S. Schallmayer, O. Pfaar, E. Coors, M. Worm, N Gebert, T. Biedermann, G. Höffken, V. Mahler, S. Michel, J. Langhorst, P. Schmid-Grendelmeier, K. Bernkopf, H. Lindemann, U. Rabe, Kirsten Beyer, L. Lange, J.-O. Steiß, Andrea Bauer, T. Jakob, F. W. Riffelmann, and S. Schnadt more...
- Subjects
medicine.medical_specialty ,Otorhinolaryngology ,business.industry ,medicine ,Immunology and Allergy ,business ,Dermatology - Published
- 2011
- Full Text
- View/download PDF
20. Intraluminal Neural therapy in Gastroenterology – Three Case Reports
- Author
-
J. Langhorst
- Subjects
medicine.medical_specialty ,Anesthesiology and Pain Medicine ,Complementary and alternative medicine ,business.industry ,Medicine ,General Medicine ,Radiology ,Neural therapy ,business - Published
- 2018
- Full Text
- View/download PDF
21. Disturbed in vitro adrenergic modulation of cytokine production in inflammatory bowel diseases in remission
- Author
-
A. Lucas, Annemieke Kavelaars, Sigrid Elsenbruch, Gustav Dobos, Guido Gerken, Cobi Jacoba Johanna Heijnen, Sebastian Haag, J. Langhorst, Pieter M. Cobelens, Gerald Holtmann, and Manfred Schedlowski
- Subjects
Adult ,Diarrhea ,Lipopolysaccharides ,Agonist ,medicine.medical_specialty ,medicine.drug_class ,medicine.medical_treatment ,Immunology ,Terbutaline ,Adrenergic ,In Vitro Techniques ,Infections ,Dexamethasone ,Monocytes ,Internal medicine ,medicine ,Humans ,Immunology and Allergy ,Glucocorticoids ,Irritable bowel syndrome ,Dose-Response Relationship, Drug ,Tumor Necrosis Factor-alpha ,business.industry ,Remission Induction ,Adrenergic beta-Agonists ,Middle Aged ,Inflammatory Bowel Diseases ,medicine.disease ,Pathophysiology ,Gastroenteritis ,Interleukin-10 ,Cytokine ,Endocrinology ,Neurology ,Neurology (clinical) ,business ,Glucocorticoid ,medicine.drug ,Psychoneuroimmunology - Abstract
Psychological stress has been implicated in the pathophysiology of both inflammatory and functional gastrointestinal (GI) diseases. The goal of this study was to address neuroendocrine modulation of cytokine production by peripheral blood cells in GI diseases.We analyzed the in vitro effects of the beta-adrenergic agonist terbutaline and the glucocorticoid agonist dexamethasone on TNF-alpha and IL-10 production by LPS-stimulated monocytes in whole cell blood cultures in patients with inflammatory bowel diseases in remission (N=10), diarrhoea-predominant irritable bowel syndrome (IBS, N=12), patients with a recent gastroenteritis (post-infectious group, N=10), and healthy controls (N=15).In response to terbutaline, there was a significant increase in IL-10 production (concentration effect: p0.05), which was diminished in IBD (group effect: p0.01), comparable in IBS and controls, but enhanced in the post-infectious group (group x concentration effect: p0.05). In contrast, terbutaline resulted in a concentration-dependent suppression of TNF-alpha production, which was comparable in all groups. Dexamethasone suppressed TNF-alpha production in a dose-dependent manner in all groups, but this effect was significantly more pronounced in post-infectious subjects (group effect: p0.05).In IBD, disturbed adrenergic regulation of IL-10 could be part of the mechanism(s) underlying the modulation of disease activity by psychological stress. Diarrhoea-predominant IBS was not associated with altered adrenergic or glucocorticoid regulation of cytokine production by peripheral blood cells, whereas a recent history of gastroenteritis was associated with disturbed neuroendocrine modulation of cytokine production, which may play role in the pathophysiology of post-infectious IBS. more...
- Published
- 2007
- Full Text
- View/download PDF
22. [Updated German clinical practice guideline on 'Diagnosis and treatment of Crohn's disease' 2014]
- Author
-
J C, Preiß, B, Bokemeyer, H J, Buhr, A, Dignaß, W, Häuser, F, Hartmann, K R, Herrlinger, B, Kaltz, P, Kienle, W, Kruis, T, Kucharzik, J, Langhorst, S, Schreiber, B, Siegmund, A, Stallmach, E F, Stange, J, Stein, and J C, Hoffmann more...
- Subjects
Crohn Disease ,Germany ,Gastroenterology ,Humans - Published
- 2014
23. [Urticaria. Sometimes IgE-mediated?]
- Author
-
D, Wieczorek, J, Langhorst, A, Kapp, and B, Wedi
- Subjects
Diagnosis, Differential ,Hypersensitivity, Immediate ,Urticaria ,Humans ,Bacterial Infections ,Autoimmune Diseases - Abstract
There are specific diagnostic recommendations for approaching chronic spontaneous urticaria, physical urticaria and special forms of urticaria. They include the detection of subclinical viral and bacterial infections, particularly with Helicobacter pylori. Frequently an autoimmune urticaria is diagnosed by using the autologous serum test. Less specific findings, such as leukocytosis and elevated CRP can sometimes be helpful in suggesting subclinical infections as the cause of acute urticaria; usually no further procedures are recommended. However, in cases with a long history of intermittent attacks, particularly with severe and generalized symptoms, it is recommended to look for IgE-mediated reactions (e.g. alpha-Gal, Omega-5-Gliadin). In our hands at the Department of Dermatology and Allergy at the Hannover Medical School a standardized set of diagnostic procedures was successfully established, and is now individually completed with selected single allergens and allergen components. more...
- Published
- 2013
24. [Mental disorders in patients with fibromyalgia syndrome: screening in centres of different medical specialties]
- Author
-
A, Galek, B, Erbslöh-Möller, V, Köllner, H, Kühn-Becker, J, Langhorst, F, Petermann, U, Prothmann, A, Winkelmann, and W, Häuser
- Subjects
Adult ,Male ,Depressive Disorder ,Fibromyalgia ,Mental Disorders ,Sick Role ,Comorbidity ,Middle Aged ,Anxiety Disorders ,Psychophysiologic Disorders ,Life Change Events ,Stress Disorders, Post-Traumatic ,Socioeconomic Factors ,Germany ,Surveys and Questionnaires ,Interview, Psychological ,Humans ,Mass Screening ,Medicine ,Female - Abstract
Systematic reviews have reported a wide range of prevalence rates for depressive, anxiety and posttraumatic stress disorders (PTSD) in patients with fibromyalgia syndrome (FMS) which have been partially explained by setting differences. No data are currently available on the prevalence of potential mental disorders depending on the medical specialty in Germany.All consecutive FMS patients of 8 study centres (3 rheumatology/orthopaedic surgery, 3 psychosomatic/pain medicine, 2 physical/integrative medicine) were assessed from February 1 to July 31, 2012 with standardised questionnaires. Patients with FMS diagnosed by a study physician were included. Non-German speaking and mentally retarded patients were excluded. The German version of the Patient Health Questionnaire 4 was used to screen for potential depressive and anxiety disorders. Severe life events were assessed by the trauma list of the Munich Composite International Diagnostic Interview and symptom criteria of PTSD of the Diagnostic and Statistical Manual of Mental Disorders IV (DSM-IV) using the Posttraumatic Diagnostic Scale.Of 538 patients, 396 patients (93.9 % women, mean age 52.3 years, mean duration since chronic widespread pain 12.8 years, mean duration since FMS diagnosis 4.5 years) were analysed. In all, 65.7 % of patients met the criteria of a potential depressive disorder, 67.9 % of a potential anxiety disorder and 45.5 % of a potential PTSD. Potential depressive disorders were more frequent in the psychosomatic/pain medicine setting than in the rheumatology setting.Potential mental disorders were frequent in FMS patients regardless of the medical specialty. All FMS patients of all types of clinical settings should be screened for mental disorders. more...
- Published
- 2013
25. [Are members of fibromyalgia syndrome self-help groups 'different'? Demographic and clinical characteristics of members and non-members of fibromyalgia syndrome self-help groups]
- Author
-
E, Jung, B, Erbslöh-Möller, M, Gesmann, H, Kühn-Becker, F, Petermann, J, Langhorst, T, Weiss, R, Thoma, A, Winkelmann, and W, Häuser
- Subjects
Complementary Therapies ,Male ,Fibromyalgia ,Comorbidity ,Middle Aged ,Relaxation Therapy ,Exercise Therapy ,Self-Help Groups ,Age Distribution ,Socioeconomic Factors ,Risk Factors ,Germany ,Prevalence ,Humans ,Female ,Chronic Pain ,Patient Participation ,Sex Distribution - Abstract
No data were available on demographic and clinical characteristics of members of fibromyalgia syndrome (FMS) self-help groups in Germany.The study was carried out from November 2010 to April 2011. A set of questionnaires was distributed by the German League Against Rheumatism and the German Fibromyalgia Association to members and to all consecutive FMS patients at nine clinical centres of different levels of care. The set included a self-developed questionnaire on demographic and medical data and on previously and currently used therapies, the patient health questionnaire (PHQ 4) and the fibromyalgia survey questionnaire.Members of FMS self-help groups (N = 1,014) were older and reported a longer duration of chronic widespread pain, less anxiety and depression and a more frequent current use of aerobic exercise, relaxation training and complementary alternative medication than participants not affiliated with FMS self-help groups (N = 630).Membership in FMS self-help groups was associated with less psychological distress and a more frequent use of active self-management strategies. more...
- Published
- 2013
26. [German fibromyalgia consumer reports. Benefits and harms of fibromyalgia syndrome therapies]
- Author
-
W, Häuser, E, Jung, B, Erbslöh-Möller, M, Gesmann, H, Kühn-Becker, F, Petermann, J, Langhorst, T, Weiss, R, Thoma, and A, Winkelmann
- Subjects
Adult ,Male ,Patient Care Team ,Analgesics ,Evidence-Based Medicine ,Fibromyalgia ,Middle Aged ,Combined Modality Therapy ,Long-Term Care ,Rehabilitation Centers ,Risk Assessment ,Patient Satisfaction ,Surveys and Questionnaires ,Humans ,Female ,Interdisciplinary Communication ,Cooperative Behavior ,Aged ,Randomized Controlled Trials as Topic - Abstract
Consumer reports provide information on benefits and harms in routine clinical care. We report the first fibromyalgia syndrome (FMS) consumer reports in Europe.The study was carried out from November 2010 to April 2011. The benefits and harms of pharmacological and non-pharmacological therapies experienced by the patient were assessed in an 11-point Likert scale (0=no, 10=very high benefit or harm) by a questionnaire. The questionnaire was distributed by the German League against Rheumatism and the German Fibromyalgia Association to their members and to all consecutive FMS patients of nine clinical centers of different levels of care.A total of 1,661 questionnaires (95% women, mean age 54 years) were analyzed. Self-management strategies (distraction, resting, aerobic exercise), physical therapies (warm and pool therapies), psychological therapies (education, psychotherapy), and inpatient multicomponent therapies were judged to be more efficacious and less harmful than all types of pharmacological therapies.The German fibromyalgia consumer reports highlight the importance of non-pharmcological therapies in the long-term management of FMS. more...
- Published
- 2012
27. [Updated German guideline on diagnosis and treatment of ulcerative colitis, 2011]
- Author
-
A, Dignass, J C, Preiss, D E, Aust, F, Autschbach, A, Ballauff, G, Barretton, B, Bokemeyer, S, Fichtner-Feigl, S, Hagel, K R, Herrlinger, G, Jantschek, A, Kroesen, W, Kruis, T, Kucharzik, J, Langhorst, M, Reinshagen, G, Rogler, D, Schleiermacher, C, Schmidt, S, Schreiber, H, Schulze, E, Stange, M, Zeitz, J C, Hoffmann, and A, Stallmach more...
- Subjects
Germany ,Humans ,Colitis, Ulcerative ,Colonoscopy - Published
- 2011
28. [Irritable bowel syndrome: German consensus guidelines on definition, pathophysiology and management]
- Author
-
P, Layer, V, Andresen, C, Pehl, H, Allescher, S C, Bischoff, M, Classen, P, Enck, T, Frieling, S, Haag, G, Holtmann, M, Karaus, S, Kathemann, J, Keller, R, Kuhlbusch-Zicklam, W, Kruis, J, Langhorst, H, Matthes, H, Mönnikes, S, Müller-Lissner, F, Musial, B, Otto, C, Rosenberger, M, Schemann, I, van der Voort, K, Dathe, and J C, Preiss more...
- Subjects
Irritable Bowel Syndrome ,Germany ,Gastroenterology ,Humans ,Delivery of Health Care - Published
- 2011
29. [Impressive picture of a melanosis coli after chronic anthraquinone laxative use--is there an increased risk for colorectal cancer?]
- Author
-
A, Abendroth, R, Klein, J, Schlaak, K A, Metz, G J, Dobos, and J, Langhorst
- Subjects
Sigmoid Diseases ,Laxatives ,Chronic Disease ,Humans ,Anthraquinones ,Female ,Colorectal Neoplasms ,Constipation ,Precancerous Conditions ,Melanosis ,Aged - Abstract
We report the case of a 74-year-old female with an extreme picture of melanosis coli of the whole colon after chronic use of anthraquinone laxatives for the treatment of constipation over many decades. Endoscopic work-up revealed an impressive deep black pigmentation of the whole colon mucosa which could be verified by histopathology as a widespread lipofuscin granulation. In addition, various adenomas but no colorectal carcinoma could be detected. The term melanosis coli describes a brown or black pigmentation of the colonic mucosa. Induction of melanosis coli by anthraquinone laxatives and their derivatives can be regarded as verified. The question if melanosis coli predisposes for colorectal neoplasia is discussed controversially. Based on the current literature, an association of melanosis coli between colorectal adenomas, but not colorectal carcinomas, is under discussion but the mechanisms to effect the development of colorectal neoplasia are not completely understood. Considering our case and the current scientific backround, we conclude that due to pharmaceutical side effects of anthraquinone derivatives such as electrolytic shift and water loss in addition to the risk of developing melanosis coli, anthraquinone laxatives should not be used for long-term therapy of constipation. more...
- Published
- 2009
30. Elevated human beta-defensin-2 levels indicate an activation of the innate immune system in patients with irritable bowel syndrome
- Author
-
Jan Wehkamp, J. Langhorst, Frauke Musial, Andreas Rueffer, Angela Junge, Dirk Foell, G. J. Dobos, and A Michalsen
- Subjects
Adult ,beta-Defensins ,Adolescent ,Colonoscopy ,Feces ,Young Adult ,Immune system ,Crohn Disease ,Immunity ,Medicine ,Humans ,Colitis ,Intestinal Mucosa ,Defensin ,Irritable bowel syndrome ,Aged ,Innate immune system ,integumentary system ,Hepatology ,medicine.diagnostic_test ,business.industry ,fungi ,Gastroenterology ,Case-control study ,biochemical phenomena, metabolism, and nutrition ,respiratory system ,Middle Aged ,medicine.disease ,Immunity, Innate ,Lactoferrin ,Case-Control Studies ,Immunology ,Colitis, Ulcerative ,business ,Leukocyte L1 Antigen Complex - Abstract
Irritable bowel syndrome (IBS) is a highly prevalent functional disorder. According to the Rome criteria, macroscopic and histological inflammation is a crucial exclusion criterion for IBS. Human defensins appear to be part of the innate immune system in the gastrointestinal tract. Human beta-defensin-2 (HBD-2) was the first inducible human antimicrobial protein discovered. The expression is induced by probiotic microorganisms and proinflammatory cytokines. Recent results imply that HBD-2 is expressed in active intestinal inflammation, especially in ulcerative colitis (UC). Our aim was to evaluate fecal measurements of HBD-2 in patients with active UC and IBS, and in healthy controls (HCs).Fecal specimens were collected from a total of 100 participants (30 with active UC, 46 IBS, and 24 HCs). Exclusion criteria were the current use of probiotics and antibiotics. Furthermore, IBS patients with elevated C-reactive protein or leukocytes, a history of bacterial overgrowth or infectious gastrointestinal disease over the last 6 month were excluded. Disease status was addressed in all participating subjects by medical history and current symptoms. In addition, each IBS and UC patient underwent ileocolonoscopy with histopathology. Fecal inflammation markers lactoferrin (Lf) and calprotectin (Cal) were measured by enzyme-linked immunosorbent assay (ELISA) and reported as microg/g. Fecal HBD-2 was measured by ELISA and reported as ng/g feces. In addition, immunoblots were performed for fecal HBD-2. Paraffin-embedded tissue from colonic biopsies was tested for HBD-2 peptides by immunohistochemistry.Lf as well as Cal was elevated in active UC (mean: 152.1+/-s.d. 374.7 microg/g; 103.5+/-87.1 microg/g), compared with IBS (8.3+/-19.4 microg/g; 18.6+/-23.3 microg/g), and HCs (0.4+/-0.5 microg/g; 7.1+/-7.9 microg/g). Scheffe post hoc tests revealed significant differences (P=0.006; P0.001) between active UC vs. IBS and HC. In contrast, HBD-2 levels were highest in active UC (mean: 106.9+/-s.d. 91.5 ng/g), almost as high in IBS (pts 76.0+/-67.9 ng/g), and lowest for HCs (29.9+/-16.1 ng/g). Scheffe post hoc tests revealed significant differences (P0.001) between the groups of patients (UC and IBS) vs. HCs. Immunohistochemical investigation was consistent with fecal secretion data and demonstrated the presence of beta-defensin 2 peptides in colonic epithelial enterocytes in UC as well as IBS patients with elevated fecal HBD-2.The results indicate significantly elevated levels of HBD-2 in patients with IBS compared with HCs and similar to those with active UC. The results support an activation of the mucosal innate defense system toward a proinflammatory response in IBS patients in the absence of macroscopic signs of inflammation. more...
- Published
- 2009
31. Erhöhtes humanes β-Defensin 2 als Indikator für eine Aktivierung des angeborenen Immunsystems bei Patienten mit Reizdarmsyndrom
- Author
-
Frauke Musial, G. J. Dobos, A. Junge, Jan Wehkamp, Dirk Foell, A Michalsen, Andreas Rueffer, and J. Langhorst
- Subjects
Gastroenterology - Published
- 2008
- Full Text
- View/download PDF
32. [Alternative and complementary therapies in fibromyalgia syndrome]
- Author
-
J, Langhorst, W, Häuser, D, Irnich, N, Speeck, E, Felde, A, Winkelmann, H, Lucius, A, Michalsen, and F, Musial
- Subjects
Complementary Therapies ,Patient Care Team ,Self-Help Groups ,Evidence-Based Medicine ,Fibromyalgia ,Germany ,Humans ,Societies, Medical - Abstract
Interdisciplinary S3 level guidelines were devised in cooperation with 8 medical, 2 psychological and 2 patient support groups. Results were elaborated in a multilevel group process.On the bases of the "Cochrane Library" (1993-2006), "Medline" (1980-2006), "PsychInfo" (2006) and "Scopus" (2006) controlled studies and meta-analyses of controlled studies were analyzed.Only few controlled studies were found supporting in part the effectiveness of CAM therapies in the treatment of fibromyalgia syndrome. Due to the lack of information on long term efficacy and cost-effectiveness, only limited recommendations for CAM therapies can be given.Within a multicomponent therapy setting, selective CAM therapies (acupuncture, vegetarian diet, homeopathy, Tai Chi, Qi Gong, music-oriented and body-oriented therapies) can be recommended for a limited period of time. more...
- Published
- 2008
33. [Stress management in the treatment of essential arterial hypertension]
- Author
-
M, Schwickert, J, Langhorst, A, Paul, A, Michalsen, and G J, Dobos
- Subjects
Time Factors ,Cognitive Behavioral Therapy ,Mind-Body Therapies ,Yoga ,Biofeedback, Psychology ,Breathing Exercises ,Meditation ,Behavior Therapy ,Hypertension ,Psychotherapy, Group ,Humans ,Autogenic Training ,Life Style ,Stress, Psychological - Abstract
Between 60 and 90% of patients consult their family doctor for stress-associated complaints. Not infrequently, a considerable number of these patients already have elevated blood pressure. The positive effect on high blood pressure of relaxation techniques has been confirmed in various studies. Accordingly, stress management should now have a permanent place in effective antihypertensive treatment. Appropriate relaxation techniques include, for example, autogenic training, progressive muscle relaxation, visualization and breathing exercises, chi gong and yoga. These practices are incorporated in various lifestyle programs. They act in different ways, and can be offered to the patient in accordance with his/her individual wishes. more...
- Published
- 2006
34. [Mind-body medicine as a part of German integrative medicine]
- Author
-
G, Dobos, N, Altner, S, Lange, F, Musial, J, Langhorst, A, Michalsen, and A, Paul
- Subjects
Delivery of Health Care, Integrated ,Mind-Body Therapies ,Germany ,Humans ,Preventive Medicine - Abstract
Mind-body medicine (MBM) as a holistic approach to health and healing has been shaped by research into stress physiology and stress psychology, by psychoneuro(endocrino)immunology and by Antonovsky's salutogenetic paradigm. MBM seeks to acknowledge physical, psychological as well as social and spiritual aspects of human beings. MBM constitutes one of the traditions, which the emerging field of integrative medicine in Germany draws upon, others being mainstream medicine, traditional European naturopathy and non-European methods like traditional Chinese medicine. The article outlines historical aspects of MBM, gives a brief review of research evidence, and introduces clinical MBM institutes in Germany. Especially the Clinic and Chair of Complementary and Integrative Medicine, Alfried Krupp von Bohlen und Halbach Foundation at the University Duisburg-Essen has been integrating MBM into the concept of integrative medicine. Considering that a growing number of health issues arises due to maladaptive lifestyles, MBM is being identified as a development that supports a shift from increasingly expensive treatments to more cost-effective preventive approaches. more...
- Published
- 2006
35. Can a novel herbal therapy have beneficial effects on maintenance of remission in ulcerative colitis?
- Author
-
Igho Onakpoya, J Langhorst, and Carl Heneghan
- Subjects
medicine.medical_specialty ,Complementary and alternative medicine ,business.industry ,Internal medicine ,Medicine ,Herbal therapy ,business ,medicine.disease ,Beneficial effects ,Ulcerative colitis ,Gastroenterology - Published
- 2014
- Full Text
- View/download PDF
36. Orale Ernergieaufnahme bei Patienten mit gastroenterologischen Karzinomen
- Author
-
M. Momma, J. Langhorst, J. Willers, M. Malandrino, Stefan Kubicka, and S. C. Bischoff
- Subjects
Nutrition and Dietetics ,Medicine (miscellaneous) - Published
- 2004
- Full Text
- View/download PDF
37. [Short-term therapeutic fasting in the treatment of chronic pain and fatigue syndromes--well-being and side effects with and without mineral supplements]
- Author
-
A, Michalsen, W, Weidenhammer, D, Melchart, J, Langhorst, J, Saha, and G, Dobos
- Subjects
Male ,Minerals ,Fatigue Syndrome, Chronic ,Chronic Disease ,Dietary Supplements ,Humans ,Pain ,Female ,Fasting ,Syndrome ,Middle Aged - Abstract
Fasting followed by vegetarian diet has shown to be an effective treatment for rheumatoid arthritis, moreover fasting is frequently used as an adjunctive treatment in chronic pain and stress/exhaustion syndromes. Data on well-being and the frequency of side effects during fasting are mostly retrospective. Mineral supplements are frequently used in order to compensate for fasting-induced tissue acidosis and to reduce side effects. There are only limited data that support this practice.To study the effects of oral mineral supplements on common side effects and well-being during short-term fasting.209 consecutive inpatients with chronic pain/exhaustion syndromes were recruited. In a controlled non-randomised study design all patients underwent fasting (250 kcal; 3 l fluid intake/day) over 7 days, in study phase 1 without (n = 103) and in study phase 2 with (n = 106) concomitant prescription of standardised oral mineral supplements (3 x 2 to 3 x 3 Bullrich's Vital). Weight, blood pressure and urinary pH were recorded daily. Well-being and mood as well as common side effects (i.e. fatigue, hunger, heart burn, headache) were assessed with standardised self-reports.Baseline characteristics of the 209 patients (mean age 54.7 +/- 10.5 years; 83.3% female) were balanced. Both groups showed a fasting-induced decrease of blood pressure, a slight decrease in mood and well-being on days 3 and 4 with consecutive increase and moderate hunger, i.e. in the evening. Side effects and general tolerability of fasting as well as well-being and mood were not different between the groups. There were no serious side effects in both groups.Short-term fasting in inpatients with pain and stress syndromes is safe and well tolerated, concomitant mineral supplements have no additive benefit. more...
- Published
- 2002
38. Evaluation of a new immunochromatographic based whole blood near patient test for the diagnosis of Helicobacter pylori infection
- Author
-
S Reichenberger, H D Schwöbel, S Heuer, H Neuhaus, J Langhorst, and F U Drouven
- Subjects
Adult ,Male ,medicine.medical_specialty ,Peptic Ulcer ,Adolescent ,Spirillaceae ,Chronic gastritis ,Rapid urease test ,Enzyme-Linked Immunosorbent Assay ,Gastroenterology ,Helicobacter Infections ,Predictive Value of Tests ,Stomach Neoplasms ,Internal medicine ,Gastroscopy ,Medicine ,Humans ,Prospective Studies ,Child ,Aged ,Aged, 80 and over ,Immunoassay ,Chromatography ,medicine.diagnostic_test ,biology ,Helicobacter pylori ,business.industry ,Esophagogastroduodenoscopy ,Gastric lymphoma ,Middle Aged ,medicine.disease ,biology.organism_classification ,Antibodies, Bacterial ,Predictive value of tests ,Gastritis ,Immunology ,Female ,medicine.symptom ,business - Abstract
Background Infection with H pylori is very common and may cause chronic gastritis, predisposes to gastric and duodenal ulcers, leads in some cases to gastric lymphoma and has been recognised as a class I gastric carcinogen. Rapid, inexpensive, reliable tests are needed to facilitate the diagnosis. Methods This prospective clinical study was undertaken to evaluate a new whole blood antibody test (helicoCare) in correlation to three tests for diagnosis of H pylori infection (histology, ELISA and rapid urease test). 304 patients (mean age 56.5 years, range of 11-93 years) referred for esophagogastroduodenoscopy were included in this uni-centric study over a nine-month period. According to the guidelines for clinical trials in H pylori infection, patients with at least two positive tests were classified as positive for H pylori. Results 132 patients (43.4 %) were positive for H pylori, of which helicoCare identified 118 missing one gastric and one duodenal ulcer. 172 patients (56.6 %) were H pylori negative, of which helicoCare identified 163. Sensitivity was proven to be 89.4 % and specificity 94.8 %. In a special subgroup of 75 patients younger or equal to 45 years, 28 patients were positive for H pylori (37.3 %). In this group a sensitivity of 85.7 % and a specificity of 97.9 % was found for the helicoCare. Conclusions The helicoCare test showed sufficient sensitivity and satisfying specificity for H pylori diagnosis similar to or better than those of rapid urease test or ELISA. The helicoCare whole blood test may be useful for in-office H pylori diagnosis especially in patients under 45 years. more...
- Published
- 2002
39. Kurzzeitiges therapeutisches Fasten in der Behandlung von chronischen Schmerz- und Erschöpfungssyndromen -- Verträglichkeit und Nebenwirkungen mit und ohne begleitende Mineralstoffergänzung
- Author
-
J. Saha, Wolfgang Weidenhammer, A. Michalsen, J Langhorst, Dieter Melchart, and G Dobos
- Subjects
medicine.medical_specialty ,Evening ,business.industry ,Chronic pain ,medicine.disease ,ddc ,Mood ,Blood pressure ,Complementary and alternative medicine ,Tolerability ,Internal medicine ,Concomitant ,Rheumatoid arthritis ,Adjunctive treatment ,medicine ,Physical therapy ,business - Abstract
Short-Term Therapeutic Fasting in the Treatment for Chronic Pain and Stress Syndromes. Effects of Mineral Supplements on Side Effects and Well-Being Background: Fasting followed by vegetarian diet has shown to be an effective treatment for rheumatoid arthritis, moreover fasting is frequently used as an adjunctive treatment in chronic pain and stress/exhaustion syndromes. Data on well-being and the frequency of side effects during fasting are mostly retrospective. Mineral supplements are frequently used in order to compensate for fasting-induced tissue acidosis and to reduce side effects. There are only limited data that support this practice. Objective: To study the effects of oral mineral supplements on common side effects and well-being during short-term fasting. Patients and Methods: 209 consecutive inpatients with chronic pain/exhaustion syndromes were recruited. In a controlled non-randomised study design all patients underwent fasting (250 kcal; 3 l fluid intake/day) over 7 days, in study phase 1 without (n = 103) and in study phase 2 with (n = 106) concomitant prescription of standardised oral mineral supplements (3 ×?2 to 3 × 3 Bullrich’s Vital). Weight, blood pressure and urinary pH were recorded daily. Well-being and mood as well as common side effects (i.e. fatigue, hunger, heart burn, headache) were assessed with standardised self-reports. Results: Baseline characteristics of the 209 patients (mean age 54.7 ??10.5 years; 83.3% female) were balanced. Both groups showed a fasting-induced decrease of blood pressure, a slight decrease in mood and well-being on days 3 and 4 with consecutive increase and moderate hunger, i.e. in the evening. Side effects and general tolerability of fasting as well as well-being and mood were not different between the groups. There were no serious side effects in both groups. Conclusions: Short-term fasting in inpatients with pain and stress syndromes is safe and well tolerated, concomitant mineral supplements have no additive benefit. more...
- Published
- 2001
40. P035 FECAL S100A12 AS NON-INVASIVE MARKER DISTINGUISHING INFLAMMATORY BOWEL DISEASE FROM IRRITABLE BOWEL SYNDROME
- Author
-
D. Foell, J. Langhorst, T. Kaiser, H. Wittkowski, A. Rueffer, G. Dobos, and J. Roth
- Published
- 2007
- Full Text
- View/download PDF
41. [General practice and patient-oriented medical education. Practicum for 'Introduction to clinical medicine (with patient examination)']
- Author
-
J, Langhorst
- Subjects
Physician-Patient Relations ,Germany ,Clinical Clerkship ,Humans ,Curriculum ,Family Practice ,Physical Examination - Published
- 1995
42. OA07.03. Randomized, double-blind, double-dummy trial of myrrh, chamomile, coffee charcoal compared to mesalazine in maintaining remission in ulcerative colitis
- Author
-
Astrid M. Westendorf, G Dobos, Rainer Stange, K. Goos, Andreas Michalsen, S. Schneider, J Langhorst, U Albrecht, A Rueffer, and M Knopp
- Subjects
0106 biological sciences ,medicine.medical_specialty ,Myrrh ,01 natural sciences ,Gastroenterology ,Double blind ,chemistry.chemical_compound ,Mesalazine ,Quality of life ,Internal medicine ,medicine ,Colitis ,Feces ,biology ,Traditional medicine ,business.industry ,General Medicine ,medicine.disease ,biology.organism_classification ,Ulcerative colitis ,3. Good health ,0104 chemical sciences ,010404 medicinal & biomolecular chemistry ,Complementary and alternative medicine ,chemistry ,Oral Presentation ,Calprotectin ,business ,010606 plant biology & botany - Abstract
Methods A total of 96 patients (51 female) with UC in remission (not longer than 12 months) were included in a randomized, double-blind, double-dummy, multicenter, non inferiority study comparing mesalazine 500 mg (3x1/d) to 100mg myrrh, 70mg chamomile extract and 50mg coffee charcoal (3 x 4/d) over a time period of 12 months. As primary outcome criterion, non-inferiority of the herbal preparation was defined and accepted, if the difference in the colitis activity index (Colitis Activity Index CAI Rachmilewitz) (calculated at six time points during the 12 month interval) averaged over all visits was ≤ 1 point. Furthermore, relapse rates, relapse-free times, safety, a comprehensive activity index (CAI, CRP and fecal Lactoferrin, Calprotectin and PMN-Elastasis), an endoscopic activity index and Health-related Quality of life (HrQoL) were assessed. Peripheral CD4+CD25+ reg T-cells were investigated in a subgroup at each time point and during a flare. more...
- Published
- 2012
43. P05.33. Becoming aware of your body: a qualitative study on yoga for chronic neck pain patients
- Author
-
H Cramer, J Langhorst, H Haller, Bettina Berger, R Lauche, and G Dobos
- Subjects
medicine.medical_specialty ,Neck pain ,Coping (psychology) ,business.industry ,Alternative medicine ,Attendance ,General Medicine ,lcsh:Other systems of medicine ,lcsh:RZ201-999 ,03 medical and health sciences ,Chronic neck pain ,0302 clinical medicine ,Complementary and alternative medicine ,Content analysis ,Family medicine ,Poster Presentation ,medicine ,Physical therapy ,030212 general & internal medicine ,medicine.symptom ,business ,Everyday life ,030217 neurology & neurosurgery ,Qualitative research - Abstract
Methods Eighteen patients with chronic non-specific neck pain participated in a 9-week Iyengar yoga-program. Before and after the program, patients were asked to complete a drawing of their neck and shoulder region in a way that reflects their subjective body perception. Semi-standardized interviews were used to retrieve more information on body perception, emotional status, everyday life and coping, and changes in these dimensions after attendance in the program. An interdisciplinary interpretation group analyzed the interviews using the content analysis approach according to Mayring. more...
- Published
- 2012
44. P02.120. Qualitative systemic review on Complementary and Alternative Medicine treatments in Inflammatory Bowel Diseases
- Author
-
P Klose, R Lauche, M Baecker, H Vorpeil, G Dobos, and J Langhorst
- Subjects
medicine.medical_specialty ,040301 veterinary sciences ,education ,Alternative medicine ,MEDLINE ,English language ,Cochrane Library ,law.invention ,0403 veterinary science ,03 medical and health sciences ,0302 clinical medicine ,Randomized controlled trial ,law ,Internal medicine ,medicine ,Methodological quality ,business.industry ,Inflammatory Bowel Diseases ,04 agricultural and veterinary sciences ,General Medicine ,3. Good health ,030205 complementary & alternative medicine ,Systematic review ,Complementary and alternative medicine ,Family medicine ,Poster Presentation ,business - Abstract
Methods A computerized search of databases (Cochrane Library, Medline, PsychINFO, and Scopus) through June 2011 was performed. We screened the reference sections of original studies and systematic reviews in the English language for CAM in IBD, CD and UC. Randomized controlled trials (RCT) and controlled trials (CT) were included. RCTs comparing treatment to controls were assessed by a methodological quality score. more...
- Published
- 2012
45. Changes of intestinal microflora in patients with rheumatoid arthritis during fasting and a Mediterranean diet
- Author
-
A Rüffer, A Michalsen, A. Junge, J. Langhorst, R. Lüdtke, G. J. Dobos, and A. Abendroth
- Subjects
medicine.medical_specialty ,Mediterranean diet ,business.industry ,Significant difference ,Food consumption ,Inflammation ,Butyrate ,medicine.disease ,Gastroenterology ,Endocrinology ,Complementary and alternative medicine ,Internal medicine ,Rheumatoid arthritis ,medicine ,Effective treatment ,In patient ,medicine.symptom ,business - Abstract
Background Therapeutic dietary interventions were often shown as effective treatment for rheumatoid arthritis (RA). Evidence 1a could be established for medical Fasting. The mechanisms to affect inflammation and clinical outcome are unknown. Alterations in intestinal microflora, especially the profile of short-chain-fatty-acids (SCFA) are believed to be associated with disease activity in patients with RA. Aim To evaluate changes in intestinal microflora and clinical outcome in RA during Fasting or a Mediterranean diet. We expect a greater influence of Fasting versus Mediterranean diet and a correlation between fasting response and alterations in SCFA. Methods In total, 50 consecutive patients from an Integrative Medicine Hospital were included in a prospective observational study. Patients received a 7-day Fasting therapy or a Mediterranean diet. Stool samples for gas-chromatographical analysis were taken at the beginning and at the end of a 2-week hospital stay. Disease activity of RA was assessed with DAS-28 and CRP was measured. Patients health assessment, self facility, pain and food consumption were evaluated with HAQ, SF-36, VAS and FFQ. Results DAS-28 decreased from 5.7±0.9 to 4.1±1.3 mean value in the fasting group and from 5.4±1.4 to 4.5±1.3 in non-fasters ( p =0.115). Pain on VAS significantly decreased from 4.1±2.3 at day 1 to 2.6±2.2 at day 7 in the fasting group versus 3.5±2.7 to 3.5±2.7 in the Mediterranean diet group ( p =0.049). CRP showed no significant difference ( p =0.759). No statistical differences between both groups were found in the profile of total-fatty-acids ( p =0.069), butyrate ( p =0.611) and propionate ( p =0.419), but measurement of acetate shows significant decrease from 17.4 μmol/g±9.8 to 21.4 μmol/g±16.4 in the fasting group compared to increasing values from 15.2 μmol/g±10.4 to 13.8 μmol/g±9.3 in the Mediterranean diet group ( p =0.044) (mean values). Conclusion Improvement of disease activity was comparable in both study groups. Pain decreased significantly on day 7 after Fasting therapy compared to Mediterranean diet and suggests a potential benefit of Fasting. Alterations in SCFA showed no significant differences except for the measurement of acetate. An association between anti-inflammatory properties of SCFA and disease activity in RA could not be shown. more...
- Published
- 2008
- Full Text
- View/download PDF
46. Shankless, a new mutation on chromosome 2 in the chicken
- Author
-
L. J. Langhorst and N. S. Fechheimer
- Subjects
Bone Development ,Mutant ,Chromosome ,Embryo ,Genes, Recessive ,Biology ,Phenotype ,Molecular biology ,Congenital Abnormalities ,Hindlimb ,Fertility ,Mutation (genetic algorithm) ,Chromosome Inversion ,Mutation ,Genetics ,Animals ,Tibia ,Molecular Biology ,Chickens ,Genetics (clinical) ,X-linked recessive inheritance ,Biotechnology ,Chromosomal inversion - Abstract
A mutant condition characterized by absence of shanks is invariably present in chickens that are homokaryotypic for an X-ray-induced pericentric inversion to chromosome 2. The mutation was studied in 260 embryos at 19 days of incubation. Embryos produced from matings of parents with and without the inversion were karyotyped and their skeletons observed and measured. The mutant phenotype, which was seen in all birds homokaryotypic for the inversion, is characterized by malformed and reduced metacarpals, absence of tarsometatarsal shanks, increased tibia length, extra bones in digits two, three, and four, and fusion of proximal phalanges. Heterokaryotypic and homokaryotypic normal embryos had normal phenotypes, but the length of metacarpals was slightly reduced in heterokaryotypes. The primary effect of the mutation is to cause misplacement, malformation, and underdevelopment of metatarsals II, III, and IV. The recessive mutation, located in the proximal region of chromosome 2, has been designated shankless (shl). more...
- Published
- 1985
47. Lifestyle Intervention Modulates the CD4+ T Cell Profile in the Blood of Crohn's Disease Patients.
- Author
-
Mekes-Adamczyk A, Gausmann N, Öznur Ö, Pfuhlmann K, Dziobaka J, Buer J, Langhorst J, and Westendorf AM
- Subjects
- Humans, Male, Female, Adult, Middle Aged, Young Adult, T-Lymphocytes, Regulatory immunology, Receptors, CCR metabolism, Flow Cytometry, Case-Control Studies, Crohn Disease therapy, Crohn Disease immunology, Crohn Disease blood, Quality of Life, CD4-Positive T-Lymphocytes immunology, Life Style
- Abstract
Background: Crohn's disease (CD) significantly affects patients' well-being and is influenced by stress and lifestyle factors, highlighting the importance of improving quality of life in CD management. An imbalance between pro- and anti-inflammatory CD4+ T cell responses is a key factor in CD, and stress has been shown to alter the function of CD4+ T cells. Therefore, this study aimed to evaluate the effect of a mind-body medicine stress management and lifestyle modification (MBM) program on the CD4+ T cell profile in CD patients., Methods: Circulating CD4+ T cells from CD patients were analyzed by flow cytometry following the MBM program. Patients were randomly assigned to either a guided intervention group (IG) or a self-guided waitlist control group (CG) over a 9-month trial and compared with healthy blood donors., Results: Lifestyle intervention reduced regulatory T cell (Treg) frequencies in the blood of CD patients. Notably, we observed a significant correlation between the quality of life improvement and Treg frequencies in the IG but not in the CG. Furthermore, differential activation and expression of the gut-homing molecules G protein-coupled receptor 15 and CCR9 on circulating Tregs and CD4+ effector T cells were detected in both the IG and CG., Conclusions: The MBM program, whether guided or self-directed, has the potential to restore the CD4+ T cell profile of CD patients to levels comparable to healthy blood donors. Lifestyle interventions may benefit CD progression, symptoms, and immunological status, but further analysis is needed to substantiate these findings and to fully understand their clinical implications. (ClinicalTrials.gov: NCT05182645)., (© The Author(s) 2024. Published by Oxford University Press on behalf of Crohn’s & Colitis Foundation. All rights reserved. For commercial re-use, please contact reprints@oup.com for reprints and translation rights for reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site—for further information please contact journals.permissions@oup.com.) more...
- Published
- 2025
- Full Text
- View/download PDF
48. Review: Food-induced mucosal alterations visualized using endomicroscopy.
- Author
-
Balsiger LM, Rusticeanu M, Langhorst J, Sina C, Benamouzig R, Huang C, Tack J, and Kiesslich R
- Subjects
- Humans, Irritable Bowel Syndrome pathology, Animals, Food Hypersensitivity, Food, Endoscopy, Gastrointestinal methods, Intestinal Mucosa pathology, Intestinal Mucosa diagnostic imaging, Microscopy, Confocal methods
- Abstract
Confocal laser endomicroscopy (CLE) is a novel technique allowing real time in vivo microscopy during standard endoscopy. Recently, acute mucosal alterations after food administration visualized by CLE have been linked to symptoms in irritable bowel syndrome (IBS). Interestingly, the observed reactions occurred in subjects without demonstrable allergic sensitization to food-this is in line with mechanistic research showing local but not systemic allergic sensitization to foods in an animal model for IBS. Here, European experts conducting CLE with food administration provide a narrative review of the available literature and propose practical guidance on the use of this technique. CLE allows physicians to observe acute mucosal reactions after the application of food to the duodenal mucosa in patients with functional gastrointestinal disorders. Some open-label interventions show a symptomatic benefit when patients exclude the nutrient that triggered an acute mucosal reaction. However, many technical, mechanistic, and clinical questions remain unanswered to date. Technically, the interobserver variability and learning curve requires systematic evaluation and criteria or cutoffs for alterations require validation. Mechanistic studies are needed to enhance our understanding of the mechanisms underlying observed alterations. Finally, rigorous blinded controlled studies are needed to assess a link of these observed alterations with symptom generation. CLE offers a platform allowing scientific insights related to food induced acute mucosal alterations. However, many questions remain unanswered, and more research is warranted to understand the role of acute mucosal alterations visualized upon food administration in IBS pathophysiology and treatment., (© 2024 John Wiley & Sons Ltd.) more...
- Published
- 2025
- Full Text
- View/download PDF
49. Effects of an integrative multimodal inpatient program on fatigue and work ability in patients with Post-COVID Syndrome-a prospective observational study.
- Author
-
Schmid S, Uecker C, Fröhlich A, and Langhorst J
- Subjects
- Humans, Female, Middle Aged, Male, Aged, Prospective Studies, Aged, 80 and over, Post-Acute COVID-19 Syndrome, Germany, Inpatients, Adult, Fatigue etiology, Fatigue therapy, COVID-19 complications
- Abstract
Post-COVID syndrome (PCS) is characterized by a variety of non-specific symptoms. One of the leading symptoms is fatigue. So far, there is no evidence-based causal therapy established and treatment of PCS is primarily symptom-oriented. The Clinic for Internal and Integrative Medicine in Bamberg, Germany, offers a comprehensive multimodal integrative inpatient therapy for PCS patients. Within a prospective uncontrolled observational study, the results of N = 79 patients were analysed. Post-COVID fatigue patients were hospitalized for up to 14 days. The treatment consists of individual modules depending on the patient's needs. It includes a wide range of integrative non-pharmacological treatment modalities. Outcomes were assessed before and after the inpatient treatment as well as 6 months after discharge from the hospital. Results show that fatigue of post-COVID patients in this study (M = 76.30, SD = 10.18, N = 64) was initially significantly higher than in the subsample "women aged 60-92 years" of the general German population (M = 51.5, Schwarz et al. [Schwarz et al. in Onkologie 26:140-144, 2003]; T(63) = 19.50, p < .001). Fatigue was significantly and clinically relevant reduced directly after discharge (M
T1 = 76.21, SD = 11.38, N = 42; MT2 = 66.57, SD = 15.55, N = 42), F(1, 41) = 19.80, p < .001, partial eta squared = .326, as well as six months after discharge (MT3 = 65.31, SD = 17.20, N = 42), F(1, 41), p < .001, partial eta squared = .371. Additionally, self-reported ability to work (NRS, 0-10) improved significantly from admission (MT1 = 2.54, SD = 2.23, N = 39) to discharge (MT2 = 4.26, SD = 2.60, N = 39), F(1, 38) = 26.37, p < .001, partial eta squared = .410), as well as to six months later (MT3 = 4.41, SD = 3.23, N = 39), F(1, 38) = 15.00, p < .001, partial eta squared = .283. The study showed that patients suffering from chronic post-COVID syndrome for several months can achieve a significant improvement in their leading fatigue symptoms and a significant improvement in the subjective assessment of their ability to work through a comprehensive two-week multimodal integrative inpatient program., Competing Interests: Declarations. Conflict of interest: None., (© 2024. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany.) more...- Published
- 2024
- Full Text
- View/download PDF
50. Participants' perspectives on a multimodal stress management and comprehensive lifestyle modification program for patients with Crohn's disease-A qualitative interview study.
- Author
-
Schlee C, Uecker C, Öznur Ö, Bauer N, and Langhorst J
- Subjects
- Humans, Female, Male, Adult, Middle Aged, Life Style, Young Adult, Combined Modality Therapy, Interviews as Topic, Mindfulness methods, Crohn Disease therapy, Crohn Disease psychology, Quality of Life, Stress, Psychological therapy, Qualitative Research
- Abstract
Background: Crohn's disease (CD) is a type of inflammatory bowel disease (IBD) that is prevalent worldwide and associated with reduced quality of life for patients. Multimodal therapy approaches, which emphasize lifestyle modifications such as mindfulness and stress reduction, can be promising in enhancing health-related quality of life for IBD patients. However, research on multimodal therapy approaches for CD remains insufficient., Method: This qualitative interview study is part of a mixed-methods approach that is embedded in a randomized controlled trial. It investigates the impact of a comprehensive 10-week day clinic lifestyle modification program on the health condition and quality of life of CD patients. Telephone interviews (n = 19) were conducted three months after the program to examine individuals' viewpoints on the intervention, including perceived changes and transfer of elements into daily life. Reflexive thematic analysis was performed using MAXQDA software., Results: The results indicate that CD can have very individual and comprehensive impacts (psychological, physical, social), leading to reduced perceived quality of life and well-being. By participating in the program, patients wanted to find self-help options to complement conventional pharmacotherapy and actively manage their disease. Patients expressed high satisfaction with the program, feeling it provided valuable support for daily disease management. They were able to integrate adequate therapy elements into their routines to complement their care. Patients recognized significant improvements in various domains, mainly in the psychological domain, e.g., improved self-efficacy, symptom management, and, also partly physical/symptomatic and social improvements., Conclusion: A multimodal stress reduction and lifestyle modification day clinic appears to be beneficial as a complementary therapy for CD patients. It offers additional options and helps patients to address individual symptoms and needs, improve their understanding of the disease and their quality of life. Although promising, further research is needed to assess its long-term effects., Trial Registration: ClinicalTrials.gov, identifier: NCT05182645., Competing Interests: I have read the journal’s policy and the authors of this manuscript have the following competing interests: JL was a speaker for Repha GmbH, Techlab Inc., Falk Foundation, Takeda, Celegene GmbH and Willmar Schwabe and received research funding from Repha GmbH, Techlab Inc., Falk Foundation and Willmar Schwabe. The sponsors had no role in the design and execution of the study, interpretation of the results or writing of the manuscript. The remaining authors declared that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright: © 2024 Schlee et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.) more...
- Published
- 2024
- Full Text
- View/download PDF
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.